Koji Hatano

The University of Osaka, Institute of Cytology

Papers

5

Total Citations

27

H-Index

2

About

Koji Hatano is a urologic surgeon and researcher whose work centers on the surgical management of renal cell carcinoma (RCC) and bladder cancer, with a particular focus on minimally invasive techniques. His major contributions include comparative effectiveness research on nephron-sparing approaches, notably demonstrating through a 2021 study that robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA) yield comparable outcomes for T1 RCC—work that has informed clinical decision-making for small renal masses. Hatano has also advanced robotic surgery, showing in a 2025 propensity score–matched analysis that robotic adrenalectomy achieves shorter operative times than traditional laparoscopy. Beyond comparative studies, he has contributed to diagnostic challenges in urologic oncology, publishing case reports on perirenal lymphadenitis mimicking renal masses and complex cystic tumors. His 2025 investigation into preoperative CRP as a predictor of prolonged hospital stay after radical cystectomy for bladder cancer reflects his interest in optimizing perioperative care. With a growing citation footprint and a portfolio spanning surgical innovation, oncologic outcomes, and predictive analytics, Hatano is establishing himself as a thoughtful contributor to evidence-based urologic surgery.

Research Focus

Key Achievements

2
H-Index
5
Papers
27
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy<i>Versus</i>Cryoablation for T1 Renal Cell Carcinoma
19 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 45
🏛 Institutions: The University of Osaka, Institute of Cytology

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago